University of Toronto, Department of Psychiatry, Toronto, Canada.
Centre for Addiction and Mental Health, Toronto, Canada.
PLoS One. 2019 Jul 15;14(7):e0219491. doi: 10.1371/journal.pone.0219491. eCollection 2019.
Relative to the large investments in mobile health (mHealth) strategies for mental illnesses such as anxiety and depression, the development of technology to facilitate illness self-management for people with schizophrenia spectrum illnesses is limited. This situation falls out of step with the opportunity mHealth represents for providing inexpensive and accessible self-care resources and the routine use of mobile technologies by people with schizophrenia. Accordingly, the focus of this study was upon the feasibility of a schizophrenia-focused mobile application: App4Independence (A4i). A4i is a multi-feature app that uses feed, scheduling, and text-based functions co-designed with service users to enhance illness self-management. This study was completed in a large urban Canadian centre and employed pre-post assessments over a 1-month period that examined medication adherence, personal recovery, and psychiatric symptomatology. App use metrics were assessed as was qualitative feedback through semi-structured interview. Findings are reported in line with the World Health Organization mHealth Evidence and Assessment (mERA) checklist. Among the 38 individuals with a primary psychosis who participated, there was no research attrition and classic retention on the app was 52.5%. Significant improvement was observed in some psychiatric symptom domains with small-medium effects. Significant change in recovery engagement and medication adherence were not observed after controlling for multiple comparisons. Those who interacted with the app more frequently were more depressed and had higher hostility and interpersonal sensitivity at baseline. Satisfaction with the app was high and qualitative feedback provided insights regarding feature enhancements. This research suggested that A4i is feasible in terms of outcome and process indicators and is a technology that is ready to move on to clinical trial and validation testing. This study contributes to the small but emergent body of work investigating digital health approaches in severe mental illness populations.
与针对焦虑和抑郁等精神疾病的大量移动医疗 (mHealth) 策略相比,开发便于精神分裂症谱系疾病患者进行疾病自我管理的技术的发展受到限制。这种情况与 mHealth 提供廉价和可及的自我护理资源以及精神分裂症患者常规使用移动技术的机会不符。因此,本研究的重点是一个专注于精神分裂症的移动应用程序的可行性:App4Independence (A4i)。A4i 是一个具有多种功能的应用程序,它使用与服务用户共同设计的饲料、调度和基于文本的功能来增强疾病自我管理。这项研究是在一个大型的加拿大城市中心完成的,采用了为期一个月的前后评估,检查了药物依从性、个人康复和精神症状。评估了应用程序的使用指标,并通过半结构化访谈提供了定性反馈。研究结果按照世界卫生组织 mHealth 证据和评估 (mERA) 清单报告。在 38 名患有原发性精神病的参与者中,没有研究流失,经典保留在应用程序上的为 52.5%。在控制了多次比较后,观察到一些精神症状领域有显著改善,具有小到中等的效果。观察到在康复参与度和药物依从性方面没有显著变化。那些与应用程序互动更频繁的人在基线时更抑郁,并且有更高的敌意和人际敏感性。对应用程序的满意度很高,定性反馈提供了有关功能增强的见解。这项研究表明,A4i 在结果和过程指标方面是可行的,并且是一种已经准备好进行临床试验和验证测试的技术。这项研究为调查严重精神疾病人群中数字健康方法的小型但新兴工作做出了贡献。